Skip to main content
Helen Brough

Dr Helen Brough

Consultant in Paediatric Allergy


Helen A. Brough MA (Hons) MSc (Allergy) PhD MBBS FRCPCH FAAAAI

Dr Helen Brough is a consultant paediatric allergist and head of the department for the largest allergic service in the UK at the Evelina London children hospital, Guy's and St Thomas' NHS Foundation Trust. Dr Brough runs general allergy clinics, joint allergy and respiratory clinics and previously ran the joint allergy and gastroenterology clinic. Dr Brough also runs allergy services for teenagers to empower them to manage their allergies. She is the Director of Children’s Allergy Doctors and private allergy clinics at the Portland Hospital for Women and Children’s Health in Marylebone, London.

Helen was the Chair of the Paediatric Section for the European Academy of Allergy and Clinical Immunology (EAACI) and represented paediatric allergy for the European Federation of Allergy and Airways Diseases (2019-2022). She was awarded the 2020 Distinguished Clinician Award by the American Academy of Asthma, Allergy and Immunology (AAAAI). She is President of the Royal Society of Medicine Allergy and Immunology Section from 2022-2024. She is on the Health Advisory Board for the UK patient advocacy group Allergy UK. Helen is an adjunct Reader at King’s College London.

She completed her MSc at the University of Southampton and her PhD at King’s College London. Helen's research interests are in eczema, genetic and environmental risk factors for the development of food allergy and the prevention, diagnosis and management of food allergy. She runs the Stopping Eczema and Allergy (SEAL) study assessing whether proactive skin care in young infants with dry skin or eczema prevents the development of food allergy. She co-authored the 2022 European guidelines for the management of atopic eczema. S

he previously led the UK arm of the Pronuts study, a multicentre European study in London, Geneva and Valencia which showed that by careful evaluation and food challenges in children with peanut, tree nut or sesame seed allergy, many nuts/ seeds can be safely tolerated. Helen was involved in the Learning Early About Peanut (LEAP), LEAP-ON and Enquiring About Tolerance (EAT) study which showed that early introduction of allergenic foods can prevent food allergy. She was also involved in peanut oral and patch immunotherapy trials that led to the first peanut oral immunotherapy product being licensed for use in children.

Dr Brough graduated from King’s College, Cambridge University with double honours in medicine and psychology before completing her clinical training at the Royal Free and University College London Medical School. She was awarded one of the few recognised UK higher specialist training posts in paediatric allergy and immunology and trained in some of the UK’s leading teaching hospitals: Guy’s and St. Thomas’ Hospital, King’s College Hospital, and Great Ormond Street Hospital. She is also certified by the European Academy of Allergology and Clinical Immunology (EAACI) as a European paediatric allergist. 

A full list of Dr Helen Brough's publications can be found on Google Scholar.


Dr Helen Brough is a leader in the following courses:

  • RSM Allergy and Immunology Section President

Dr Helen Brough is a teacherin the following courses:

  • MSc Allergy (Imperial)
  • Allergy Academy (King's)
  • Quality Improvement workshop (King's)